Skip to main content
. 2021 Apr 23;75(8):564–571. doi: 10.1136/jclinpath-2020-207356

Figure 1.

Figure 1

Comparison of antibody titres using different testing platforms. COVID-19 positive control samples (n=24) were measured on the anti-RBD IgG (A) and IgM (B) ELISAs as well as on the Ortho VITROS total anti-SARS-CoV-2 Ig platform (C). ELISA measurements reported as titres and were converted to a log 10 scale (A, B). Ortho VITROS measurements reported as signal to cut-off ratio (S/C) (C). IgG titres below 1:100, IgM titres below 1:40, and S/C values below 1.0 were considered negative. Bars represent the median and IQR (A–C). Titers are shown on logarithmic scale. RBD, receptor binding domain.